👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

TD Cowen increases Revvity stock price target, keeps buy on stable signs

EditorNatashya Angelica
Published 11/05/2024, 11:32 PM
RVTY
-

On Tuesday, TD Cowen demonstrated confidence in Revvity Inc (NYSE: RVTY) shares by increasing the stock's price target to $144 from the previous $141. The firm maintained a Buy rating on the shares, signaling a positive outlook for the company's future performance. The adjustment follows Revvity's recent financial disclosures and market activities.

Revvity's third-quarter results indicated that instrument sales, particularly in China and the rest of the world, were a notable weak point. Management has acknowledged this by lowering the fourth-quarter guidance to account for the continuation of this trend. Despite these challenges, the company has shown signs of stability and improvement across its product portfolio.

The analyst from TD Cowen highlighted that Revvity's solid cost controls, efforts to reduce debt, and increased capital return through buybacks contribute to an attractive investment setup. These factors, combined with a valuation that sits at the midpoint of the sector, are seen as positive indicators for Revvity's performance leading into the year-end and through 2025.

Revvity's commitment to maintaining financial discipline while navigating market difficulties is reflected in the company's strategic decisions. The firm's ability to manage costs effectively and its initiative to reward shareholders through buybacks have been well-received by analysts.

Investors are now eyeing Revvity Inc as the company approaches the year-end, with expectations set for its performance in the upcoming year. The price target upgrade by TD Cowen suggests a belief in the company's potential to thrive amid the current market conditions and beyond.

In other recent news, Revvity Inc reported impressive third-quarter results, with revenue and earnings per share surpassing consensus estimates. The company's adjusted revenue stood at $684 million, marking a 2% organic growth, while the adjusted EPS was $1.28, exceeding expectations by $0.16. In light of these strong results, Baird has raised its price target for Revvity from $136 to $138 and maintains an Outperform rating on the stock.

Despite some market challenges, particularly in China, Revvity's overall business trajectory remains favorable. The company has announced a $1 billion share repurchase authorization, reflecting its confidence in its financial health. However, it has slightly lowered its revenue guidance for 2024, while increasing its EPS guidance by approximately $0.10 at the midpoint.

Revvity's Q4 organic growth is anticipated to be between 3% to 5%, with full-year revenue for 2024 expected to range between $2.75 billion and $2.77 billion. The software segment is projected to experience low double-digit growth for the year. These are among the recent developments at Revvity, as the company continues to navigate the market dynamics.

InvestingPro Insights

Revvity Inc's recent performance and TD Cowen's optimistic outlook are further supported by real-time data from InvestingPro. As of the latest available data, Revvity boasts a market capitalization of $15.39 billion, reflecting its significant presence in the market. The company's P/E ratio of 57.84 indicates that investors are willing to pay a premium for its shares, possibly due to growth expectations.

InvestingPro Tips highlight Revvity's financial stability and growth potential. One key tip notes that the company "has maintained dividend payments for 54 consecutive years," underscoring its commitment to shareholder returns, which aligns with TD Cowen's positive view on capital return through buybacks. Moreover, Revvity "operates with a moderate level of debt," which supports the analyst's observation about the company's efforts to reduce debt.

Despite the challenges in instrument sales mentioned in the article, InvestingPro data shows that Revvity's revenue for the last twelve months as of Q2 2024 stood at $2.71 billion. While this represents a slight decline of 4.54% year-over-year, the company's gross profit margin remains robust at 55.26%, indicating strong pricing power and operational efficiency.

For investors seeking a deeper understanding of Revvity's potential, InvestingPro offers 11 additional tips, providing a comprehensive analysis of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.